Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Cardiometabolic Control by Angiotensin II Type 1 Receptor-Expressing Agouti-Related Peptide Neurons

Award Number: F30DK149444
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 09/01/2026
PERIOD OF PERFORMANCE END DATE: 08/31/2030

Group Awards By:

View Award Description

Cardiometabolic Control by Angiotensin II Type 1 Receptor-Expressing Agouti-Related Peptide Neurons - PROJECT SUMMARY Cardiovascular disease (CVD) remains the leading cause of mortality in the United States. Obesity and its comorbid conditions including high blood pressure (BP), type 2 diabetes, and hyperlipidemia, are significant risk factors which predispose to CVD. While weight loss is a key strategy to mitigate CVD risk, long-term weight maintenance is difficult, in part, due to metabolic adaptation, which reduces resting metabolic rate (RMR) in response to prolonged energy deficit. This proposal investigates the neural mechanisms governing RMR, focusing on the brain renin-angiotensin system (RAS) and its role in the arcuate nucleus of the hypothalamus (ARC), a critical brain region for energy homeostasis. Our laboratory has identified a novel subpopulation of Agouti-related peptide (AgRP) neurons within the ARC, termed 'Type 1 AgRP neurons,' where angiotensin II (ANG II) signaling via the ANG II type 1 receptor (AT1R) normally inhibits neuronal activity. Crucially, we have discovered that diet-induced obesity causes a G protein signaling switch in these neurons, altering ANG II/AT1R signaling from inhibitory (Gαi-coupled) to stimulatory (Gαq-coupled). The functional consequences of obesity- induced plasticity in this neuronal population are unknown and represent a critical knowledge gap in understanding RMR dysregulation. This project aims to elucidate the role of Type 1 AgRP neurons on the downstream control of RMR and cardiovascular function. The central hypothesis is that this obesity-induced signaling plasticity in Type 1 AgRP neurons represents a maladaptive mechanism contributing to impaired metabolic homeostasis and that these neurons serve as critical regulators of both RMR and BP. This will be addressed through two aims: Aim 1: Define the contribution of Type 1 AgRP neurons to cardiometabolic control in lean animals. We hypothesize that Gαi-mediated inhibition of Type 1 AgRP neurons will increase RMR and blood pressure and reduce heart rate without altering feeding behavior. This will be investigated using an intersectional genetic approach to selectively express inhibitory DREADDs (hM4Di) in Type 1 AgRP neurons, followed by comprehensive cardiometabolic phenotyping. Aim 2: Test the hypothesis that chronic activation of Gαq in Type 1 AgRP neurons, simulating maladaptive G protein signaling plasticity in obesity, impairs metabolic homeostasis, impairs metabolic homeostasis and promotes weight regain. We will use an intersectional viral strategy to express Gαq-DREADDs specifically in Type 1 AgRP neurons to determine if chronic activation exacerbates metabolic dysfunction, impairs weight loss after obesity, and accelerates weight regain. By defining the functional and unique contribution of Type 1 AgRP neurons to metabolic and cardiovascular control, this work may identify new therapeutic targets to selectively modulate RMR for sustained weight loss without the adverse cardiovascular effects common to other strategies. Through this multidisciplinary project, I will gain mastery of advanced neuroscience and cardiometabolic phenotyping, providing critical training for my growth into an independent physician-scientist.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $54,484 )
2026	2026	THE MEDICAL COLLEGE OF WISCONSIN, INC.	8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	MILWAUKEE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	1	8/17/2026	NEW	$0
2026	2026	THE MEDICAL COLLEGE OF WISCONSIN, INC.	8701 WATERTOWN PLANK RD	MILWAUKEE	WI	53226	MILWAUKEE	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	8/17/2026	NEW	$54,484
														Subtotal = $54,484

Grand Total All Awards = $54,484

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Cardiometabolic Control by Angiotensin II Type 1 Receptor-Expressing Agouti-Related Peptide Neurons

Award Number: F30DK149444

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 09/01/2026

PERIOD OF PERFORMANCE END DATE: 08/31/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer